Tempus

Introducing Tempus: Personalized Healthcare Solutions 🌐 At Tempus, we are revolutionizing healthcare through the power of artificial intelligence and data. With our extensive library of clinical and molecular data, starting with cancer, we provide personalized healthcare solutions that empower patients, physicians, and life sciences companies. Here are some key features that set us apart: 🤖 AI Clinical Assistant - Tempus One: Our AI-enabled clinical assistant puts patient insights directly at clinicians' fingertips, using generative AI to provide real-time information for informed treatment decisions. 🧬 Genomic Profiling: We offer genomic profiling and algorithmic tests that help physicians make more informed treatment decisions, bringing personalized medicine to the forefront. 🔎 Clinical Trial Matching: With our platform, physicians can easily search for up-to-date clinical trials based on specific criteria, ensuring patients have access to the latest treatment options. 💻 Digital Pathology: Tempus provides digital pathology services, including Tempus Pixel, offering therapy response evaluation and specialized disease areas such as lung, breast, neuro, and cardio. 🔬 Sequencing and Data Collaborations: We offer sequencing services and actively promote data collaborations to drive better drug development and research. 🔍 Clinical Research Services: Our services aid in clinical trial enrollment, with Tempus PRO™ as a dedicated platform for neurology and psychiatry. 📚 Publications: Stay informed with our regular research publications, webinars, and resources on personalized healthcare developments. Here are some use cases where Tempus makes a difference: 👩‍⚕️ Providers: We empower physicians to make more informed treatment decisions, giving them the tools they need for personalized patient care. 🧪 Life Sciences: Tempus supports pharmaceutical and biotech companies in their quest for better drug development, leveraging our extensive data and expertise. 👥 Patients: We help patients find their own unique and optimal therapy options, putting their needs and preferences at the forefront. We are proud of our notable achievements, which include: 🏆 Tempus' xT Platform increases cancer patients' personalized therapeutic opportunities, bringing new hope and possibilities. 💉 Tempus' HLA-LOH assay received Breakthrough Device Designation from the FDA as a companion diagnostic test, paving the way for more accurate treatment decisions. 🔬 We recently launched Tempus xR, a standalone RNA next-generation sequencing assay, further expanding our capabilities and offerings. 💼 Tempus has forged partnerships with 90% of the top 20 pharma oncology companies and more than 200 biopharma partnerships, solidifying our position as a leader in the field. 🌎 Over 50% of all Academic Medical Centers and oncologists in the US are connected to Tempus, making our network comprehensive and far-reaching. 📊 With over 6,000,000+ de-identified research records and identification of over 24,000+ patients for potential enrollment into clinical trials, Tempus is driving groundbreaking research and advancements. Tempus is at the forefront of personalized healthcare, bringing AI, data, and expertise together to improve patient outcomes. Experience the future of healthcare with Tempus today.